The groundbreaking treatment of tirzepatide peptide represents a major breakthrough in the management of the condition. Different to existing therapies, tirzepatide impacts multiple pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – providing improved sugar management and p